Correlation of the Lung Immune Prognostic Index (LIPI) and PDL1 status with outcomes for immune checkpoint inhibitors in advanced NSCLC patients Meeting Abstract
| Authors: | Mezquita, L.; Park, W.; Arbour, K.; Auclin, E.; Hendriks, L.; Planchard, D.; Saravia, D.; Ponce Aix, S.; Nadal, E.; Audigier-Valette, C.; Carnio, S.; Adam, J.; Ruffinelli, J. C.; Zalcman, G.; Numico, G.; Sullivan, I.; Paz-Ares, L.; Dingemans, A.; Novello, S.; Hellmann, M.; Lopes, G.; Besse, B. |
| Abstract Title: | Correlation of the Lung Immune Prognostic Index (LIPI) and PDL1 status with outcomes for immune checkpoint inhibitors in advanced NSCLC patients |
| Meeting Title: | IASLC 19th World Conference on Lung Cancer |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 13 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2018 Sep 23-26 |
| Meeting Location: | Toronto, Canada |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2018-10-01 |
| Start Page: | S488 |
| Language: | English |
| ACCESSION: | WOS:000454014501258 |
| DOI: | 10.1016/j.jtho.2018.08.624 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P1.01-68 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work